United States Preclinical In-vivo Imaging Market 2025: Advances Growth Opportunities & Industry Insights | TriFoil Imaging, PerkinElmer, VisualSonics Inc. (Fujifilm), MILabs B.V, Mediso Ltd

Preclinical In-vivo Imaging Market size was valued at USD 936.1 million in 2022 and is estimated to reach at a compound annual growth rate (CAGR) of 6.40% over the forecast period 2024-2031.

DataM Intelligence has released its latest report on the "Preclinical In-vivo Imaging Market Size 2025," providing a detailed analysis of market trends, key growth drivers, competitive landscape, and regional insights. The report includes market size (value and volume), CAGR projections, and emerging opportunities that help businesses identify growth areas and build effective strategies. Backed by data-driven insights and future outlook, this study serves as a valuable resource for companies looking to stay competitive and capitalize on market potential.

United States: Recent Industry Developments
✅ October 2025: Bruker Corporation unveiled enhanced small animal MRI systems with improved resolution for oncology research.
✅ September 2025: PerkinElmer expanded its preclinical imaging service offerings with integrated PET/MRI platforms.
✅ August 2025: NIH funded projects to advance in-vivo imaging biomarkers for neurodegenerative disease models.

Japan: Recent Industry Developments
✅ October 2025: Shimadzu Corporation launched innovative preclinical optical imaging solutions for drug discovery applications.
✅ September 2025: Fujifilm invested in multimodal imaging technologies combining CT and fluorescence for enhanced in-vivo studies.
✅ August 2025: Collaborative efforts between academia and industry promoted the adoption of AI-enhanced image analysis tools.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/preclinical-in-vivo-imaging-market?kb

Latest M&A

In February 2024, Bruker Corporation acquired Spectral Instruments Imaging (SII) for $37.5 million, enhancing its preclinical optical imaging capabilities including bioluminescent and fluorescent imaging systems.​

Other strategic acquisitions and collaborations in 2025 continue involving key players such as PerkinElmer, Siemens Healthineers, and Revvity focusing on expanding molecular imaging and multi-modal preclinical platforms.​

Additional partnerships with technology firms are facilitating advances in AI-driven image analysis and spatial transcriptomics integration.​

Key Player:

Siemens A.G, TriFoil Imaging, PerkinElmer, VisualSonics Inc. (Fujifilm), MILabs B.V, Mediso Ltd and Agilent Technologies.

Forecast Projection:

The global Preclinical In-vivo Imaging market is set to witness strong growth from 2025 to 2032. After maintaining steady momentum in 2024, the market is expected to accelerate as key industry players implement strategic initiatives to boost adoption. Companies that adapt to these emerging trends will be well-positioned to capture new opportunities and enhance their revenue potential throughout the forecast period.

Market Intelligence Research Process:

The Preclinical In-vivo Imaging Market Report by DataM Intelligence offers a comprehensive analysis built on a mix of primary and secondary research. It explores key factors driving the industry, including government policies, market trends, competitive landscape, technological advancements, and upcoming innovations. This in-depth study uncovers both growth opportunities and potential challenges, helping businesses navigate market fluctuations and make data-driven decisions for sustainable success.

Buy Now & Get 30% OFF - (Grab 50% OFF on 2+ reports) @ https://www.datamintelligence.com/buy-now-page?report=preclinical-in-vivo-imaging-market?kb

Key Segmentations:

By Modality: (Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-MRI Systems, Micro-Ultrasound Systems, Micro-CT Systems, Preclinical Photoacoustic Imaging Systems, Preclinical Magnetic Particle Imaging (MPI) Systems)

By Reagent: (Preclinical Optical Imaging Reagents, Preclinical Nuclear Imaging Reagents, Preclinical MRI Contrast Agents, Preclinical Ultrasound Contrast Agents, Preclinical CT contrast agents)

By Application: (Research and development, Drug discovery)

By Distribution Channel: (Pharmaceutical companies, Biotechnology companies, Research institutes, Others)

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/preclinical-in-vivo-imaging-market?kb

FAQ's

Q1: How large is the Preclinical In-vivo Imaging Market?

Ans: The Preclinical In-vivo Imaging Market size was valued at USD 936.1 million in 2022

Q2: How quickly is the Preclinical In-vivo Imaging Market expanding?

Ans: The Preclinical In-vivo Imaging Market is forecasted to grow at a CAGR of 6.40% between 2025 and 2032, showing Annual growth momentum

Q3: Which regions are dominating the Preclinical In-vivo Imaging Market and which are fastest-growing?

Ans: North America dominating the Preclinical In-vivo Imaging market.

FDA Developments

FDA accepted a new drug application for MK-6240, a PET imaging agent targeting tau protein in Alzheimer's Disease, set for Prescription Drug User Fee Act (PDUFA) review in 2026 advancing diagnostic imaging agents as adjuncts in drug development.​

FDA payment reforms in 2025 aimed to stabilize reimbursement for nuclear medicine and radiopharmaceutical imaging, supporting advanced diagnostic throughput.​

The FDA roadmap is reorienting to reduce animal testing while enhancing imaging-based safety assays as surrogate endpoints in preclinical trials

Have any Query We Will Provide in Detailed @ https://www.datamintelligence.com/enquiry/preclinical-in-vivo-imaging-market?kb

Reimbursement

CMS finalized a policy to allow separate payments for high-value radiopharmaceutical diagnostics surpassing threshold costs, enhancing reimbursement stability for preclinical imaging agents and diagnostics used in drug development.​

Payers are increasingly recognizing the value of advanced in-vivo molecular imaging to reduce late-stage clinical trial failures and support personalized medicine approaches.

Get 2-Day Free Trial + 50% OFF DataM Subscription@ https://www.datamintelligence.com/reports-subscription?kb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
Linkedin: https://www.linkedin.com/company/datam-intelligence/
Twitter: https://x.com/DataM_Research

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.